The Claim
Carriers of genetic variants in the PCSK9 gene that lower LDL cholesterol exhibit a statistically significant reduction in carotid artery intima-media thickness, a marker of subclinical atherosclerosis, suggesting that genetically determined lower LDL cholesterol levels are associated with reduced arterial plaque accumulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People who naturally have lower 'bad' cholesterol because of their genes tend to have cleaner arteries, which means less buildup of plaque over time.
See the scientific wording
Carriers of LDL-lowering PCSK9 variants have slightly but significantly lower carotid artery intima-media thickness, a marker of subclinical atherosclerosis, indicating that genetically reduced LDL cholesterol is associated with less arterial plaque buildup.
What the research says
1 studyStudy: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
People born with certain PCSK9 gene changes have lower 'bad' cholesterol and much lower chances of heart disease, which supports the idea that lower cholesterol from these genes means less artery damage over time.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.